KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Liabilities and Shareholders Equity (2016 - 2025)

LifeMD filings provide 14 years of Liabilities and Shareholders Equity readings, the most recent being $70.4 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 7.47% to $70.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $283.6 million, a 3.52% increase, with the full-year FY2025 number at $70.4 million, down 7.47% from a year prior.
  • Liabilities and Shareholders Equity hit $70.4 million in Q4 2025 for LifeMD, up from $66.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $76.1 million in Q4 2024 to a low of $16.4 million in Q3 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $45.3 million (2021), compared with a mean of $47.9 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 718.13% in 2021 and later crashed 48.59% in 2022.
  • LifeMD's Liabilities and Shareholders Equity stood at $49.9 million in 2021, then tumbled by 48.59% to $25.7 million in 2022, then soared by 127.85% to $58.5 million in 2023, then soared by 30.12% to $76.1 million in 2024, then decreased by 7.47% to $70.4 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $70.4 million (Q4 2025), $66.0 million (Q3 2025), and $73.6 million (Q2 2025) per Business Quant data.